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Abstract: Electrospinning is an enabling technology that can architecturally (in terms of 
geometry, morphology or topography) and biochemically fabricate engineered cellular scaffolds 
that mimic the native extracellular matrix (ECM). This is especially important and forms one 
of the essential paradigms in the area of tissue engineering. While biomimesis of the physical 
dimensions of native ECM’s major constituents (eg, collagen) is no longer a fabrication-related 
challenge in tissue engineering research, conveying bioactivity to electrospun nanoﬁ  brous 
structures will determine the efﬁ  ciency of utilizing electrospun nanoﬁ  bers for regenerating 
biologically functional tissues. This can certainly be achieved through developing composite 
nanoﬁ  bers. This article gives a brief overview on the current development and application status 
of employing electrospun composite nanoﬁ  bers for constructing biomimetic and bioactive tissue 
scaffolds. Considering that composites consist of at least two material components and phases, 
this review details three different conﬁ  gurations of nanoﬁ  brous composite structures by using 
hybridizing basic binary material systems as example. These are components blended composite 
nanoﬁ  ber, core-shell structured composite nanoﬁ  ber, and nanoﬁ  brous mingled structure.
Keywords: electrospinning, composites, nanoﬁ  ber, tissue scaffolds, biomimetic, bioactive
Introduction
Electrospinning and tissue engineering scaffolds
Electrospinning, which is an ultraﬁ  ne ﬁ  ber manufacturing technology, was coined in 
the 1990’s from the earlier used term of “electrostatic spinning” (Formhals 1934) by 
Reneker and co-workers (Doshi and Reneker 1995; Reneker and Chun 1996). It has 
now attracted increasingly worldwide attention in both the academic community and 
industrial world (Reneker and Chun 1996; Huang, Zhang et al 2003; Li and Xia 2004). 
Electrospinning is capable of fabricating ﬁ  bers with nanometer scale diameters that 
yield very high speciﬁ  c surface area – up to one to two orders of magnitude higher 
than micrometer scale ﬁ  bers produced by conventional melting and dry/wet spinning 
methods. Electrospun nanoﬁ  bers are therefore very useful for developing a variety of 
products or structures whose functional efﬁ  ciency is surface area dependent. Among 
those potential applications proposed (Huang, Zhang et al 2003; Li and Xia 2004; 
Zhang, Lim et al 2005), construction of biomimetic1 cellular scaffold will represent one 
of the most promising applications for the electrospun nanoﬁ  bers. Using ‘Electrospin-
ning’ as the keyword for literature searching through the ISI Web of Science®, it was 
found that, of the top 10 most cited articles2 out of more than 1000 relevant papers, 3 of 
1Refers to an artiﬁ  cial material or structure that mimics a biological material/structure/function.
2As of May 7, 2007, the top 10 most cited articles from ISI Web of Science® are: 1) Reneker DH, Chun 
I, 1996. Nanotechnology, 7(3):216–23. (448 times). 2) Doshi J, Renker DH, 1995. J Electrost, 35 
(2–3):151–60. (362 times). 3) Reneker DH, Yarin AL, Fong H, et al. 2000. J Appl Phys, 87 (9):4531–47. 
(302 times). 4) Huang ZM, Zhang YZ, Kotaki M, et al. 2003. Compos Sci Technol, 63 (15):2223–53. (284 International Journal of Nanomedicine 2007:2(4) 624
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them pertain to the subject of nanoﬁ  brous tissue scaffolding 
applications with the other 7 articles being either reviews 
or related to the process of electrospinning. The underlying 
rationale of using nanoﬁ  bers for constructing cellular scaf-
folds is based on the biomimesis principle that electrospun 
nanoﬁ  bers can mimic the physical structure of the major 
constructive elements in the native ECM as biologically, 
almost all of the tissues and organs such as bone, skin, tendon 
and cartilage, are synthesized and hierarchically organized 
into ﬁ  brous form (structure) with ﬁ  ber dimensions down to 
nanometer scale (Nishida, Yasumoto et al 1988; Kadler, Hol-
mes et al 1996). Nanoﬁ  brous scaffold could therefore provide 
environmental or physical cues to the cells and promote cell 
growth and function well towards the synthesis of genuine 
extracellular matrices over time (Laurencin, Ambrosio et al 
1999). Unlike other types of architectural scaffolds, using 
electrospun nanoﬁ  ber for scaffolding implies that while the 
nanoﬁ  brous scaffold is responsible for the overall mechanical 
properties of the tissue or cell-scaffold complex, the nano-
level structures (nanoﬁ  bers) can provide nanomechanical and 
biodegradation properties for cells to proactively interplay 
with the provisional matrix and functionalize and remodel 
it, similar to that of the native cellular remodeling process 
within the ECM.
Thus, electrospinning has recently established the reputa-
tion for its capability to make ECM-mimicking scaffolds, 
and is counted as a new addition to the conventional scaffold 
fabrication techniques (eg, solvent-casting and particulate-
leaching, gas foaming, ﬁ  ber bonding, freeze drying, etc). 
However, despite the increasing interest in electrospinning 
for the past decade, making use of electrospun nanoﬁ  bers for 
tissue engineering has only a mere short history of about 5–7 
years (Fertala, Han et al 2001; Stitzel, Pawlowski et al 2001; 
Li, Laurencin et al 2002). Both the design, fabrication of the 
nanoﬁ  brous scaffolds and molecular level understanding of 
the interactions in vitro between the nanoﬁ  brous scaffolds and 
mammalian cells as well as in vivo tests and applications are 
still in the early stage of development. With respect to the mate-
rials used in electrospinning in the very ﬁ  rst few years since 
2001, traditional synthetic biodegradable aliphatic polyesters 
such as PLA, PLGA, and PCL are still the preferred and 
prevailing choices of materials for constructing nanoﬁ  brous 
scaffolds due to their well-known good processability and 
mechanical performance. Obviously, in the context of biomim-
icking nanoscale ﬁ  bers, these electrospun synthetic polymers 
have replicated the physical dimensions and morphology of the 
major component collagen in the native ECM. Yet, two persis-
tent problems can restrain the synthetic polymeric nanoﬁ  bers 
from being effective during application. Firstly, unlike natural 
biopolymers, the pristine synthetic polymers lack cell recog-
nition sites on the scaffold surfaces and that means poor cell 
afﬁ  nity (Hubbell 1995; Cai, Yang et al 2002; Rosso, Marino 
et al 2005). Secondly, the aggravated hydrophobicity arising 
from their inherent hydrophobic attribute (Chen, Ushida et al 
2000; Cai, Wan et al 2003) and nanoscale effect (Feng, Li et al 
2002; Neimark, Kornev et al 2003) will affect cell seeding on 
the nanoﬁ  brous scaffolds and subsequent cellular activities. In 
addition, their acidic degradation products have detrimental 
effects to the cells. Hence, despite the scaffold being porous 
and possessing higher surface area, poor hydrophilicity will 
cause a majority of the pores to remain empty, potentially 
resulting in the underutilization of the 3-D scaffolds. These 
are certainly the immediate problems to be addressed prior 
to effective use.
Why composite nanoﬁ  bers?
The above noted problems demand for the development of 
bioactive3 and functional electrospun nanoﬁ  bers. Essen-
tially, it is related to the biochemical attributes of the used 
materials. The most ideal candidate materials should be the 
native biomaterials such as collagen. However, one of the 
shortcomings for collagen is its inadequate mechanical prop-
erties after being processed from its native form. Thus, an 
alternative solution will be to make appropriate modiﬁ  cation 
to the synthetic polymers. Whilst traditional surface chemical 
modiﬁ  cation approaches used on the bulk synthetic poly-
mers can be applied to ameliorate the synthetic nanoﬁ  bers, 
simple physical hybridizing synthetic polymers with bioac-
tive natural biopolymers and then converting the hybrids 
into nanoﬁ  bers will offer a more facile and cost-effective 
times). 5) Fong H, Chun I, Reneker DH. 1999. Polymer, 40 (16):4585–92. (279 times). 6) Deitzel JM, Kleinmeyer J, Harris D, et al. 2001. Polymer, 
42 (1):261–72. (259 times). 7) Li WJ, Laurencin CT, Caterson EJ, et al. 2002. J Biomed Mater Res, 60 (4):613–21. (227 times). 8) Matthews JA, 
Wnek GE, Simpson DG, et al. 2002. Biomacromolecules, 3 (2):232–8. (218 times). 9) Yoshimoto H, Shin YM, Terai H, et al. 2003. Biomaterials, 
24 (12):2077–82. (192 times). 10) Li D, Xia YN. 2004. Adv Mater, 16 (14):1151–70. (186 times). Articles 7–9 are pertaining to tissue scaffolding 
applications.
3The term ‘bioactive’ usually refers to a material or structure that would have positive effect on the living cells in vitro and/or in vivo, due to it 
containing certain bioactive substances such as proteins (eg, peptides, collagens). The bioactive substances can be physically (eg, via blending) or 
chemically (eg, by covalently immobilization) incorporated into the material. In this paper, we deﬁ  ne a nanoﬁ  ber being bioactive if it promotes cell-scaffold 
interaction in terms of cellular adhesion, proliferation, migration, maintaining normal cell morphology and functions, etc.International Journal of Nanomedicine 2007:2(4) 625
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route for modifying and tailoring the material properties. By 
deﬁ  nition, composite materials or composites are made from 
two or more components. As natural and synthetic polymers 
constitute the largest fraction of biomaterials for tissue scaf-
folding, here we will deﬁ  ne a composite ﬁ  ber as one whose 
materials are compounded from one synthetic sourced 
polymer and one from natural sourced polymer or inorganic 
nanoparticles. Unlike traditional engineering composites 
where inorganic components such as carbon and glass ﬁ  bers 
are used to reinforce the matrix material, the natural biopoly-
mers used are to impart bioactivity to the biologically pas-
sive synthetic polymers. With the versatile electrospinning, 
such composite nanoﬁ  bers can be designed and fabricated 
in the form of either basically random blending or ordered 
structure (eg, core-sheath) from the available synthetic and 
natural polymers. A number of merits are conceivable with 
such composite nanoﬁ  bers. Physically, the new composite 
nanoﬁ  bers could provide better hydrophilicity (wettability) 
and improved mechanical properties, etc. Biologically, the 
incorporation of bioactive macromolecules (eg, collagenous 
proteins or growth factors) into the synthetic components 
could promote cell-surface recognition and also promote or 
control many aspects of cell physiology such as adhesion, 
spreading, activation, migration, proliferation and differentia-
tion (Drumheller and Hubbell 2000). Due to the size of the 
nanoﬁ  bers, such effects are being augmented or made more 
effective because of the high surface area for cells to access. 
Additionally, as controlled and sustained delivery of growth 
factors are deemed necessary for successful tissue engineer-
ing (Baldwin and Mark Saltzman 1998; Ikada and Tabata 
2002), the biomimetic composite nanoﬁ  bers, in particular, 
core-sheath structure could perform controlled and effective 
delivery of bioactive molecules purely from the nanoﬁ  brous 
scaffolds without using extra delivery devices.
Here, we will focus on composite nanoﬁ  brous scaffolds 
primarily made from biodegradable synthetic and natural 
materials. Using a binary hybridizing system as an illustra-
tion, composite nanoﬁ  bers in the forms of randomly blended 
structure, core-shell structure, and mingled nanofibers 
(Figure 1) will be the major three types of composite nano-
ﬁ  bers discussed. Since composites involve different phases, 
the illustrations in Figure 1 also reﬂ  ect the typical different 
phase separation or existence states in a biphasic structured 
composites or hybrid nanoﬁ  bers.
Components blended composite 
nanoﬁ  brous scaffolds
The components blended composite nanofibers can be 
divided into two categories, ie, organic-organic blends and 
organic-inorganic blends. Both will be discussed in the fol-
lowing two sub-sections.
Organic-organic blends
As mentioned above, the organic-organic blends is meant 
to be made from synthetic and natural sourced polymers 
with improving bioactivity and functions as the chief 
concern. Table 1 gives a summary of organic-organic blend 
nanoﬁ  brous scaffolds which have been explored by different 
researchers. As one of the earliest groups of applying the 
composite concept for developing biomimetic and bioactive 
nanoﬁ  brous scaffolds, we have demonstrated the efﬁ  cacy 
of using a combination of the natural collagen-derived bio-
polymer gelatin (Gt) with the synthetic poly(ε-caprolactone) 
(PCL) to acquire desired physical, chemical and biological 
properties of nanoﬁ  brous scaffolds (Zhang, Ouyang et al 
2005). Our results showed that composite nanoﬁ  brous scaf-
fold Gt/PCL had very good wettability and/or hydrophilic-
ity and balanced mechanical properties compared to its 
Component A Component B
a b c
Figure 1 Schematic cross-sectional views of different structures of composite nanoﬁ  bers from components of A and B. (a) randomly blended; (b) core-shell structured; and 
(c) nanoﬁ  bers-mingled (from concurrent electrospinning).International Journal of Nanomedicine 2007:2(4) 626
Zhang et al
constituents. In vitro cell culture experiments manifested 
very signiﬁ  cant cell proliferation and inﬁ  ltration compared to 
the biologically inert synthetic PCL alone scaffolds. Cellular 
inﬁ  ltration into the Gt/PCL composite nanoﬁ  brous scaffolds 
up to 110 μm was, for the ﬁ  rst time, quantitatively measured 
through a laser scanning microscopy. The favorable cellular 
responses were attributed to the materials hybridization 
effect. Introduction of the bioactive biopolymer of Gt into the 
PCL had remarkably improved the wettability and cell afﬁ  n-
ity of the ﬁ  brous scaffolds. Although electrospun nanoﬁ  brous 
scaffolds are deemed porous with interstices formed by ﬁ  ber 
interlacing, the ‘pores’ formed would be much smaller than 
the normal cell size of a few to tens of microns which could 
inhibit cell migration to the interior of the electrospun nanoﬁ  -
brous structure. Nevertheless, we speculate that three factors 
could be responsible for the observed cellular inﬁ  ltration 
phenomenon. Firstly, the introduction of natural biopolymer 
of Gt into the PCL confers good hydrophilicity/wettability 
and biological recognition signals, which will consequently 
facilitate nutrients/oxygen transfer and removal of metabolic 
products and encourage pioneering cells to migrate deeper 
into the scaffold. Such a favorable local microenvironment 
as a result of material constituents can deﬁ  nitely modulate 
the cellular responsive behaviour (Chen, Ushida et al 2002; 
Coombes, Verderio et al 2002; Telemeco, Ayres et al 2005). 
Secondly, Gt/PCL composites had lower tensile strength, 
but very good elongation and deformation properties. These 
favorable mechanical properties can provide easier opening 
of spaces for cell penetration to deeper levels of the scaffold. 
Matched nanomechanical properties will be one of the impor-
tant factors to account for cell penetration. The resilience and 
deformability of scaffolds at nano-, meso-, and macro-scale 
do inﬂ  uence in vitro migration and morphology of cells 
(Carnegie and Cabaca 1993). Lastly, the gelatin component in 
the Gt/PCL scaffold is gradually dissolved during cell culture 
resulting in the emergence of porous ﬁ  bers. This will in situ 
make extra space for cell migration and easy transportations 
of nutrients and waste. The formation of 3-D porous ﬁ  bers 
was demonstrated in our later study (Zhang, Feng et al 2006) 
by leaching the gelatin component out of the composite ﬁ  bers 
as shown in Figure 2. The 3-D porous ﬁ  ber morphology also 
suggests that the phase separation of gelatin and PCL in 
the composite nanoﬁ  bers is in a randomly blended fashion. 
Further, BET surface area measurement indicated that the 
3-D porous ﬁ  bers possessed a surface area of about 2.4 times 
that of the pristine Gt/PCL ﬁ  bers. With these encouraging 
results, very recently we have electrospun Gt/PCL composite 
nanoﬁ  bers onto a polyurethane dressing (Tegaderm™, 3M 
Medical) for potential dermal wound healing application 
(Chong, Phan et al 2007). Signiﬁ  cant cell adhesion, growth 
and proliferation on the Tegaderm-nanoﬁ  ber construct were 
achieved, providing great potential and feasibility in the 
treatment of wounds through layered dermal reconstitu-
tion. In another study using a similar strategy, Li et al (Li, 
Mondrinos et al 2006) also fabricated gelatin-containing 
composite nanoﬁ  brous scaffolds of PLGA/gelatin/elastin for 
potential soft tissue engineering applications. The cultured 
H9c2 rat cardiac myoblasts and rat bone marrow stromal 
cells (BMSCs) were found to grow well and cell penetration 
into the scaffolds were also observed through histological 
characterization. These studies also indicate that as the bioac-
tive component of gelatin is a hydrogel dissolvable in water, 
blending gelatin with a structural stable synthetic polymer 
to form composites circumvents the chemical cross-linking 
a b
Figure 2 SEM images of 3-D porous ﬁ  bers (a) after gelatin was leached out of the electrospun Gt/PCL composite ﬁ  bers (b) (Zhang, Feng et al 2006). Scale bar 2 μm.International Journal of Nanomedicine 2007:2(4) 627
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related cytotoxicity problem of gelatin scaffolds (Zhang, 
Venugopal et al 2006).
It is also noted that many investigations are based on the 
collagen/synthetics blends to produce biomimetic and bioactive 
scaffolds. Bioactivity and/or biofunctions have been remarkably 
achieved in the nanoﬁ  brous form. These studies have similarly 
demonstrated that compared to the synthetic nanoﬁ  brous coun-
terparts, collagen-containing composite nanoﬁ  brous scaffolds 
facilitated cell adhesion (Stankus, Guan et al 2004; Kwon and 
Matsuda 2005; Li, Mondrinos et al 2006; Park, Kang et al 2006; 
Venugopal, Zhang et al 2006; Meng, Kim et al 2007; Schnell, 
Klinkhammer et al 2007), spreading (He, Yong et al 2005; Kwon 
and Matsuda 2005; Venugopal, Zhang et al 2006), viability (He, 
Yong et al 2005; Schnell, Klinkhammer et al 2007), migration 
(Stankus, Guan et al 2004; Sell, McClure et al 2006; Schnell, 
Klinkhammer et al 2007), proliferation (Stankus, Guan et al 
2004; Kwon and Matsuda 2005; Venugopal, Zhang et al 2006; 
Meng, Kim et al 2007; Schnell, Klinkhammer et al 2007), 
phenotypic morphological preservation and differentiation (He, 
Yong et al 2005; Schnell, Klinkhammer et al 2007), and possible 
collagenase degradation function (Stankus, Guan et al 2004). In 
addition, introduction of collagen in processing can facilitate the 
generation of even ﬁ  ner electrospun ﬁ  bers (Kwon and Matsuda 
2005; Li, Guo et al 2006; Li, Mondrinos et al 2006; Park, Kang 
et al 2006; Venugopal, Zhang et al 2006). Apart from these gela-
tin/collagen/elastin-containing composite nanoﬁ  brous scaffolds, 
in a different strategy, Li et al fabricated polyaniline (PANi)-
contained gelatin composite nanoﬁ  brous scaffolds by doping 
gelatin with a small amount of conductive polymer PANi and 
demonstrated biocompatibility of such conductive nanoﬁ  brous 
Table 1 Organic–organic blend composite nanoﬁ  brous scaffolds
Scaffold materials  Solvents  Diameters of   Cells cultured  Potential uses   References
 used  electrospun     for  tissue   
   ﬁ  bers    engineering 
DNA/PLGA or PLA–  DMF/Tris–EDTA  250–875 nm,  A pre–osteoblastic  Bone  (Luu, Kim et al 2003)
PEG block copolymer  buffer  375 nm–1.1μm  cell line, MC3T3E1   
       
Gelatin/PCL  TFE  500–900 nm  BMSCs, Fibroblasts  Skin  (Zhang, Ouyang et al 2005;
          Chong, Phan et al 2007)
Collagen/PEUU  HFIP  100–900 nm  smooth muscle cells  Soft tissues  (Stankus, Guan et al 2004)
       
Collagen/Elastin/PEO  Aqueous HCl  220–600 nm  SMCs  Blood vessel  (Buttafoco, Kolkman et al
        2006)
PLCL/Collagen (or   HFIP  120–520 nm  HUVEC  Vascular graft  (Kwon and Matsuda 2005)
Heparin)       
NGF–BSA/PCLEEP DCM/PBS  0.5~3.0μm  PC12 cells  Nerve  (Chew, Wen et al 2005)
Collagen/GAG(eg, CS)  TFE/Water  260 nm  RCFs  /  (Zhong, Teo et al 2005)
Collagen/Elastin/PLGA HFIP  720 ± 350 nm  Bovine endothelial and  Vascular substitute  (Stitzel, Liu et al 2006)
(blend ratio 45:15:40)      smooth muscle cells   
Gelatin/PANi  HFIP  60–800 nm  H9c2 rat cardiac  Cardiac/nerve  (Li, Guo et al 2006)
     myoblast 
Gelatin/Elastin/PLGA HFIP  380 ± 80 nm  H9c2 rat cardiac   Heart/blood  (Li, Mondrinos et al 2006)
     myoblast,  BSCs  vessel
Collagen/P(LLA–CL)  HFIP  100–300 nm  HCAECs  Blood vessel  (He, Yong et al 2005)
PGA/Chitin  HFIP  50–350 nm  Fibroblasts  /  (Park, Kang et al 2006)
PHBV/Collagen  HFIP  300–600 nm  NIH3T3  /  (Meng, Kim et al 2007)
PDO/Elastin  HFIP  400–800 nm  Human dermal  Vascular graft  (Sell, McClure et al 2006)
     ﬁ  broblasts
GDNF/PCLEEP DCM/PBS  3.96 ± 0.14μm  In vivo test  Nerve  (Chew, Mi et al 2007)
Collagen/PCL  HFIP  ~275 nm  HDFs  Skin  (Venugopal, Zhang et al
        2006)
Collagen/PCL (75:25)  HFIP  541 ± 164  nm  Schwann cells,  Nerve  (Schnell,
     ﬁ  broblasts, olfactory    Klinkhammer et al 2007)
     ensheathing  cells
Abbreviations: BMSC: bone marrow stromal cell; BSA, bovine serum albumin; CS, chondroitin sulfate; DCM, dichloromethane; DMF, dimethylformamide; GAG, glycos-
aminoglycan; GDNF, human glial cell–derived neurotrophic factor; HCAEC, human coronary artery endothelial cell; HCl, hydrochloric acid; HDF, human dermal ﬁ  broblast; 
hESF, human embryo skin ﬁ  broblast; HUVEC, human umbilical vein endothelial cell; HFIP, hexaﬂ  uoroisopropanol; NGF, nerve growth factor; P(LLA–CL), poly(L–lactic 
acid)–co–poly(ε–caprolactone); PANi, polyaniline; PBS, phosphate buffered saline; PCL, poly(ε–caprolactone); PCLEEP, polymer(ε–caprolactone–co–ethylethylene phosphate); 
PDO, polydioxanone; PEG, poly(ethylene glycol); PEO, poly(ethylene oxide); PEUU, poly(ester urethane)urea; PGA, poly(glycolic acid); PHBV, poly(3–hydroxybutyrate–co–3–
hydroxyvalerate); PLA, polylactide; PLCL, poly(L–lactide–co–ε–caprolactone); PLGA, poly (D,L–lactide–co–glycolide); PlnDI, perlecan domain I; PVA, poly(vinyl alcohol); RCF, 
rabbit conjunctiva ﬁ  broblast; SMC, Smooth muscle cell; TFE, triﬂ  uoroethanol.International Journal of Nanomedicine 2007:2(4) 628
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scaffolds (Li, Guo et al 2006). This groundwork will prompt 
future probing of the electroactive effect of such scaffolds for 
engineering cardiac or neuronal tissues. In another study, for even 
better mimicking of the natural ECM which is mainly composed 
of collagen and glycosaminoglycans (GAGs), Zhong et al pre-
pared collagen/condroitin sulfates composite nanoﬁ  brous scaf-
folds and demonstrated their excellent biocompatibility through 
conducting in vitro culturing of rabbit conjunctive ﬁ  broblasts on 
the developed scaffolds (Zhong, Teo et al 2005).
Although the above attempts of introducing natural mate-
rials have resulted in improved biological properties, there 
appeared some biophysical and mechanical inadequacies 
with these systems. One of the noted problems is the dis-
solving solvent which implicates modiﬁ  cation to the natural 
biopolymer structure. As seen in Table 1, except work by 
Buttafoco et al (2006) where aqueous acidic solutions were 
used for electrospinning collagen/elastin/PEO blends, almost 
all the other composite nanoﬁ  bers produced employed the 
strong polarity organic solvent of ﬂ  uorinated alcohols, in 
particular the HFIP as the dissolving solvent. The reason 
is that to have the blend of collagen/synthetics successfully 
electrospun, selecting an organic solvent which is capable of 
dissolving both the collagen and the used synthetic polymer 
is a prerequisite. In this regard, the specialty organic solvents 
such as HFIP, TFE which can dissolve a wide range of 
polymers including those tough polymers such as polygly-
colide, polyamides, polypeptides, could be the only choice 
as collagen is insoluble in the ordinary organic solvents. 
Huang et al (Huang, Nagapudi et al 2001) once attempted 
electrospinning collagen dissolved in a traditional weak acid 
solution. However, very high ﬁ  ber-forming aiding agent 
PEO with a ratio of more than 50% was used. Later, with 
HFIP as the dissolving solvent, Matthews et al (Matthews, 
Wnek et al 2002) successfully electrospun pure collagens 
into nanoﬁ  bers and demonstrated the collagen’s banding 
characteristic remains. In addition to its high polarity strong 
dissolving capability to various polymers, its other physical 
properties such as being volatile, miscible with water and 
many organic solvents, and low surface tension also favor 
it to be an ideal solvent for electrospinning. But, HFIP is 
a rather costly organic solvent. And there are also reports 
that using HFIP could modify the collagen native structure. 
For example, Stankus et al (Stankus, Guan et al 2004) used 
circular dichroism spectroscopy to evaluate the preservation 
of collagen secondary structure in the electrospun PEUU/col-
lagen blends and found signs of some structural modiﬁ  cation, 
in particular to those blends with collagen contents less than 
50%. Previously, Doillon et al also investigated the negative 
inﬂ  uence of HFIP on the secondary structure of collagen 
(Doillon, Drouin et al 1997). Although using the high polar 
HFIP is still disputable, the relatively less polar TFE could 
be an alternative choice of candidate solvent because TFE 
could facilitate reconstruction of the helical conﬁ  guration 
of collagen (Buck 1998). In another of our work on cross-
linking the electrospun gelatin nanoﬁ  bers, we found that 
the ‘crystallinity’ which reﬂ  ects the triple-helix content was 
increased by about 20% (Zhang, Venugopal et al 2006). 
Despite gelatin being a denatured substance from collagen 
which involves rupture of the triple-helix structure by break-
ing the hydrogen bonds and rearranging the triple helix into 
a random conﬁ  guration, under proper conditions, the chains 
are able to undergo a conformational disorder-order transition 
to recover the triple-helix structure (Pezron, Djabourov et al 
1991; Ross-Murphy 1992). Another issue is it has been com-
monly found that the random blending system gave rise to a 
decrease in certain mechanical properties, eg, tensile strength, 
especially for the blending ratio of natural components up to 
50% in the blending system (Stankus, Guan et al 2004; He, 
Yong et al 2005; Kwon and Matsuda 2005; Zhang, Ouyang 
et al 2005; Sell, McClure et al 2006). Severe phase separa-
tion and weak physical interactions between the binary blend 
system are probably responsible for the weakening mechani-
cal performance (Zhang, Ouyang et al 2005; Park, Kang 
et al 2006; Zhang, Feng et al 2006). Mechanical properties 
are of crucial important in scaffold design for engineering 
load-bearing tissues. Electrospun nanoﬁ  bers are able to 
emulate the nanoscale collagen in the ECM, which means 
matched nanomechanical properties to the cells. However, 
the macroscopic mechanical properties of their assembled 
form (eg, ﬁ  brous membranes) did not seem comparable to 
other types of scaffolds fabricated from the same materials. 
In this regard, besides optimizing the constituent ratio to 
minimize the decrease in mechanical properties of compos-
ite nanoﬁ  bers, combination of nanoﬁ  bers with other types 
of substrate such as microﬁ  bers and ﬁ  lms could be a better 
solution for load-bearing tissue regeneration (Tuzlakoglu, 
Bolgen et al 2005; Sahoo, Ouyang et al 2006; Chong, Phan 
et al 2007; In Jeong, Kim et al 2007).
As mentioned before, introduction of structural proteins 
such as collagen (gelatin) and elastin is one of the approaches 
to improve the physicochemical and biological properties of 
the nanoﬁ  brous scaffolds. However, bioactivity of electrospun 
nanoﬁ  brous scaffolds can also be achieved through incorpo-
rating very tiny amount of function-regulating biomolecules 
such as DNA and a variety of growth factors into the scaffolds. 
Thereafter, they can then be released out of the scaffolds in a International Journal of Nanomedicine 2007:2(4) 629
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controlled manner to the cell microenvironment to modulate 
cell behavior. In such a case, the scaffold works additionally 
as a drug delivery functional device. For example, Luu et al 
demonstrated the ﬁ  rst successful incorporation of DNA into 
the electrospun PLGA random copolymer and PLA-PEG 
block copolymer nanoﬁ  brous scaffolds for gene delivery 
(Luu, Kim et al 2003). The loaded DNA was claimed to be 
able to be sustainably released over a period of 20 days with 
the scaffold still structurally intact and capable of cell transfec-
tion and bioactivity. In another study, Chew et al investigated 
the feasibility of encapsulating human β-nerve growth factor 
(NGF) in an electrospun scaffold of ε-caprolactone and ethyl 
ethylene phosphate (PCLEEP) copolymer (Chew, Wen et al 
2005). PC12 neurite outgrowth assay suggested a partial retain-
ing of the bioactivity. Furthermore in another study, human 
glial cell-derived neurotrophic factor (GDNF, 0.13 wt%) was 
encapsulated in the PCLEEP for in vivo testing the efﬁ  cacy of 
electrospun aligned protein/polymer composite ﬁ  bers through a 
rat model for peripheral nerve-injury treatment (Chew, Mi et al 
2007). Deﬁ  nitely, drug-loaded composite nanoﬁ  brous scaffolds 
have great potential in locally controlling the cellular process. 
However, retention of bioactivity and realization of controlled 
delivery of the loaded bioactive molecules remain to be the 
major research interests of utilizing nanoﬁ  bers. More improve-
ments and exploration are clearly needed in this context.
Organic-inorganic blends
For organic-inorganic blends, inorganic nanoparticles have 
often been incorporated into polymer matrix to add function-
alities and/or to improve mechanical properties for bone tissue 
engineering as summarized in Table 2. Generally, inorganic 
phase such as bioactive nanoparticles nano-hydroxyapatite 
(nHA) (Kim, Song et al 2005; Kim, Lee et al 2006; Li, Vepari 
et al 2006; Thomas, Jagani et al 2006; Wutticharoenmongkol, 
Sanchavanakit et al 2006; Venugopal, Vadgama et al 
2007), carbon nanotubes (CNT) (Saeed, Park et al 2006; 
Jose, Steinert et al 2007), nanoclays (Ji, Li et al 2006) and 
whiskers(Junkasem, Rujiravanit et al 2006) have been reported 
for preparing nanoﬁ  brous tissue engineering scaffolds. Bone is 
a natural composite material which is composed of an organic 
matrix (mostly type I collagen) with an array of inorganic apa-
tite nanocrystals. To mimic the bone structure, hydroxyapatite 
and other calcium phosphate in combination with biodegrad-
able and biocompatible polymers are natural choices for bone 
tissue engineering application. Fujihara et al (2005) reported 
polycaprolactone PCL/CaCO3 composite nanoﬁ  bers with two 
different PCL to calcium carbonate (CaCO3) ratios (PCL:
CaCO3 75:25 wt% and 25:75 wt%). Good cell attachment was 
observed for the studied composition range, which indicated 
a potential to utilize PCL/CaCO3 composite nanoﬁ  bers to 
guide bone regeneration (GBR) membranes. Similar results 
were reported for composite nanoﬁ  bres of hydroxyapatite 
nanoparticles incorporated in other polymer systems such as 
synthetic poly(lactic acid) (Kim, Lee et al 2006) and natural 
polymers (eg, gelatin (Kim, Song et al 2005) and silk (Li, 
Vepari et al 2006)). Incorporating cell-signaling molecules 
such as RGD peptides and growth factors have been proven 
to further improve the cellular behaviour of the tissue engi-
neering scaffolds. Venugopal, Vadgama et al (2007) reported 
a signiﬁ  cant increased mineralization (55%) in PCL/nHA/
Table 2 Organic – inorganic blend composite nanoﬁ  brous scaffolds
Scaffold materials  Solvents  Diameters of   Cells cultured  Potential uses for   References
    electrospun     tissue engineering 
   ﬁ  bers     
HA/Gelatin  HFIP  200–400 nm  human osteoblastic   bone  (Kim, Song et al 2005)
     cells  MG63   
PCL/CaCO3 Chloroform/  760 ± 190 nm  human osteoblast  bone  (Fujihara, Kotaki et al 
 Methanol    hFOB1.19    2005)
PHBV/HAp  TFE  100–2,000 nm  COS– 7 cells from the  /  (Ito, Hasuda et al 2005)
     monkey  kidney 
HA/PLA Chloroform  1~2  μm  MG63 cells  bone  (Kim, Lee et al 2006)
Silk/PEO/nHAP/BMP– 2  water  520 ± 55 nm  hMSCs  bone  (Li, Vepari et al 2006)
PLLA/HA  DCM/1,4-dioxane  <500 nm  human osteosarcoma  bone  (Deng, Sui et al 2007)
     MG–  63 
PCL/HA/Collagen HFIP  373 ± 191 nm  hFOB  bone  (Venugopal, Vadgama
          et al 2007)
PLLA/MWCNT/HA  DCM  250–950 nm  DPSCs  dental  (Deng, Xu et al 2007)
Abbreviations: BMP– 2, bone morphogenetic protein 2; CaCO3, calcium carbonate; DCM, dichloromethane; DPSC, dental pulp stem cell; HA/nHAP/HAp, hydroxyapatite; 
HFIP, hexaﬂ  uoroisopropanol; hFOB, human fetal osteoblasts; hMSC, human bone marrow– derived mesenchymal stem cell; MWCNT, multi– wall carbon nanotube; PHBV, 
poly(3– hydroxybutyrate– co– 3– hydroxyvalerate); PLLA, poly(L– lactic acid); PCL, poly(ε– caprolactone); PEO, poly(ethylene oxide); PLA, polylactide; TFE, triﬂ  uoroethanol.International Journal of Nanomedicine 2007:2(4) 630
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Collagen biocomposite nanoﬁ  brous scaffolds after 10 days of 
cell culture using human fetal osteoblast cells (hFOB). They 
concluded that such a unique combination of nanostructures 
and bioactivity in nanoﬁ  brous scaffolds had inherent surface 
functionality for hFOB adhesion, migration, proliferation and 
mineralization to form a bone tissue. Li et al (Li, Vepari et al 
2006) reported electrospun silk ﬁ  broin nanoﬁ  brous scaffolds 
containing bone morphogenetic protein 2 (BMP-2) and/or 
nanoparticles of hydroxyapatite for in vitro bone formation 
from human bone marrow-derived mesenchymal stem cells 
(hMSCs). They found that the co-existence of BMP-2 and 
nHA in the electrospun silk ﬁ  broin nanoﬁ  bers resulted in 
the highest calcium deposition and upregulation of BMP-2 
transcript levels when compared with other systems.
Apart from the compositions of composite nanoﬁ  bers, 
the nano-/micro-structures and ﬁ  ber morphology have 
also been reported to have signiﬁ  cant effects on biological 
responses, which ultimately are dependent on fabrica-
tion processing. So far, most of the nanocomposites were 
fabricated by mixing nanoparticles with polymers using 
simple stirring and ultrasoniﬁ  cation for dispersion. The 
particle size of nHA ranged from 10 nm to 150 nm. One 
of the processing related problems was the agglomeration 
of nanoparticles due to their large surface areas and sur-
face interactions. The reported micro-/nano-structures of 
composite nanoﬁ  bers had neither uniform distribution of 
nHA within polymer matrix nor controlled orientation and 
alignment of non-spheric nanoparticles such as HA nano-
plates or CNTs. This not only compromises the mechani-
cal properties but may also take a longer time to remodel 
into bone tissue during regeneration for such composite 
nanoﬁ  bers in contrast to the native ECM. To overcome this 
problem, the interfacial forces between nanoparticles and 
polymers have to be carefully manipulated. Kim et al (2006) 
reported the use of a surfactant hydroxysteric acid (HSA) 
to control the interaction between the hydrophilic nHA 
powders and the hydrophobic chloroform-dissolved PLA. 
They found improved dispersability of nHA powders and 
resulted uniformality of composite nanoﬁ  bers. However, 
the ﬁ  ber diameters were still relatively large (1–2 μm), a 
common feature for electrospun ﬁ  bers made from ﬁ  lled 
nanoparticles. To mimic the structures and compositions 
of human tissues, a biomimetic approach has to be adopted 
(Chan, Kumar et al 2006).
Signiﬁ  cant progress in understanding of hierarchical 
structure of bone in the past decades has prompted research 
into how to build a scaffold that mimics the bone structure. 
Bone is a hierarchically structured material with remarkable 
mechanical properties. It is regarded as a nanocomposite 
material which is made up of hydroxyapatite nanocrystals and 
collagen over several length scales. The current approaches 
by utilizing nHA particles with particle sizes of tens or hun-
dreds nanometers are far from ideal to mimic the natural bone 
structures where the nHA is typically platelike with a dimen-
sion of 50 × 25 × 3 nm (Landis, Song et al 1993). Various 
attempts have been carried out since the late 1990s to perform 
biomimetic synthesis of nHA/collagen nanocomposites and 
composite scaffolds (Bradt, Mertig et al 1999; Du, Cui et al 
2000). But thus far, it has failed to produce any electrospun 
composite nanoﬁ  bers because of the processing difﬁ  culty 
in electrospinning of aqueous mineralised collagen system. 
A recent study on gelatin/HA biomimetic nanoﬁ  bers was 
attempted to produce nanoﬁ  bers for guided tissue regenera-
tion. Kim et al (Kim, Song et al 2005) used a co-precipitation 
method to produce biomimetic gelatin/HA nanocomposite 
from both Ca- and P-containing gelatin solutions under 
alkaline condition at 40 °C. After washing and freeze 
drying, the co-precipitated nanocomposite was re-dissolved 
in a highly polar solvent, 1,1,1,3,3,3-hexaﬂ  uoro-2-propanol 
(HFIP). Such ﬂ  uorinated alcohols have been widely used 
in electrospinning of natural biopolymers such as collagen 
(Matthews, Wnek et al 2002) and gelatin (Zhang, Ouyang 
et al 2005). TEM micrographs revealed improved homogene-
ity over nanoparticles ﬁ  lled nanoﬁ  bers. More importantly, 
the selected area electron diffraction (SAED) revealed a 
diffusion ring pattern on elongated HA crystals, which was 
characteristic of the typical apatite structure when grown 
in a biomimetic process where the mediation of the amino 
acid structure in the collagen-based organic matrix induced a 
preferential apatite growth along its c-axis direction (Kikuchi, 
Ikoma et al 2004). The disadvantages of ﬂ  uorinated alcohols 
such as HFIP are their costs, possible toxicity and environ-
mental concerns. The future directions in electrospinning of 
biomimetic nanocomposite ﬁ  bers should focus on the use of 
more eco-friendly aqueous system which mimics more the 
in vivo cellular growth conditions of tissues.
Core-shell structured composite 
nanoﬁ  brous scaffolds
Another category of composite nanoﬁ  bers is in the form 
of core-shell or core-sheath structure. Conventionally, 
a core-sheath larger sized ﬁ  ber consists of a core of one 
type of polymer and a shell of a different polymer. The 
mechanical properties of the ﬁ  ber are chieﬂ  y dictated by 
the core material, whereas the shell polymer offers external 
functions or properties (eg, adhesion, friction, softness). International Journal of Nanomedicine 2007:2(4) 631
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With electrospinning, core-shell structured nanoﬁ  bers can 
be produced as well.
Coaxial electrospinning
Feasibility of fabricating core-shell nanoﬁ  bers through a tech-
nique called coaxial electrospinning have been recently dem-
onstrated by several research groups (Loscertales, Barrero 
et al 2002; Sun, Zussman et al 2003; Li and Xia 2004; Yu, 
Fridrikh et al 2004; Zhang, Huang et al 2004). Essentially, 
coaxial electrospinning is a modiﬁ  cation or extension to the 
ordinary electrospinning process. The major difference is 
that coaxial electrospinning employs a compound spinneret 
which consists of one (or more) inner capillary housed by an 
outer tube from which different ﬂ  uids are separately fed into 
their respective channels and integrated into a core-sheath 
structured composite ﬁ  ber as they are charged and emitted 
from the compound spinneret.
With coaxial electrospinning, at least four types of functional 
nanoﬁ  bers (Figure 3) can be envisioned and actually have been 
demonstrated workable in the past few years. The basic ﬁ  ber 
form is generally of concentric bi-component in morphology 
or surface-coating like form dependent on control of processing 
parameters while coaxial electrospinning two homogeneous 
solutions (Figure 4a). If nanoparticles-containing ﬂ  uid was 
used as core dope, nanoparticles-loaded composite nanoﬁ  bers 
can be prepared (Figure 4b). Li et al and Loscertales et al have 
creatively demonstrated the feasibility of directly performing 
one-step fabrication of hollow nanoﬁ  bers (Figure 4c) via com-
bining the coaxial electrospinning and sol-gel chemistry (Li and 
Xia 2004; Loscertales, Barrero et al 2004). Furthermore, very 
recently Zhao et al developed multichannel microtubes (Fig-
ure 4d) by extending the two-channel coaxial electrospinning 
approach (Zhao, Cao et al 2007) to multi-channels. Obviously, 
coaxial electrospinning provides a novel route to design and 
fabricate a variety of functional nanoﬁ  ber structures.
The prospect of core-shell structured nanoﬁ  bers from coax-
ial electrospinning looks very attractive to numerous industrial 
applications. However, current investigation on this technique 
is still quite limited and some issues such as the mechanism of 
forming core-shell structure and processing control on core-
sheath conﬁ  guration remain to be thoroughly investigated. With 
respect to the formation mechanism of core component, some 
researchers suggested that the rapid stretching of the sheath 
causes strong viscous stress, which will be passed onto the core 
ﬂ  uid. The shear stress would stretch the core component and 
elongate it along with the sheath solution via mechanism such 
as viscous dragging and/or contact friction (Li and Xia 2004; 











Figure 3 Illustrated cross-sectional views of a variety of novel and functional polymeric nanoﬁ  bers from coaxial electrospinning, including basic bi-component nanoﬁ  ber, 
surface coated/modiﬁ  ed nanoﬁ  ber through tuning the sheath thickness, nanoparticles encapsulated nanocomposite nanoﬁ  ber, and hollow nanoﬁ  bers where the core com-
ponent is removed.International Journal of Nanomedicine 2007:2(4) 632
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of conditions can high yield of core-shell structured nanoﬁ  bers 
be produced, and how those commonly appreciated process-
ing variables such as applied electric ﬁ  eld strength, solution 
viscosity and/or concentrations, and ﬂ  ow rate would affect 
the control of sheath-thickness as well as the resultant ﬁ  ber 
dimensions. Presently, our work indicated that by altering the 
inner polymer solution concentrations and ﬂ  ow rates, both the 
inner and overall diameter of coaxially electrospun bi-compo-
nent nanoﬁ  bers can be consequently changed (Zhang, Huang 
et al 2004; Zhang, Wang et al 2006). Li et al investigated the 
inﬂ  uences of varying ﬂ  ow rate and electrical strength. They 
found increasing the feeding rates led to larger inner diameter, 
and both the inner and outer diameters of the core-shell ﬁ  bers 
decreased as the electrical ﬁ  eld was enhanced.
As bioactive tissue scaffolds
Coaxial electrospun core-shell structured composite nanoﬁ  bers 
can be used for constructing bioactive cellular scaffolds by using 
electrospinnable bioactive macromolecules such as collagen as 
the shell (to impart bioactivity) and synthetic polymer as core 
(to retain mechanical and structural advantage). This concept 
and efﬁ  cacy have been demonstrated in our group (Zhang, 
Venugopal et al 2005). In this work, we examined the cell 
proliferation and morphological differences by culturing human 
dermal ﬁ  broblasts (HDFs) on the collagen-r-PCL (representing 
collagen and PCL being the shell and core, respectively) scaf-
folds, and other substrates for comparison including electrospun 
nanoﬁ  brous scaffolds of PCL and collagen, tissue culture plate 
(TCP) control, and collagen-coated electrospun PCL prepared 
by immersing the electrospun PCL into a collagen solution 
overnight. After 6 days of culture, it was found that nanoﬁ  bers 
with coatings either achieved by coaxial electrospinning or by 
simple immersion-coating were deﬁ  nitely favorable for cell pro-
liferation. But, the efﬁ  ciency is dependent on coating approaches 
used. Compared to pure nanoﬁ  brous PCL, the HDFs density on 
the core-shell nanoﬁ  brous scaffolds increased linearly by 19.5% 
(2 days), 22.9% (4 days), and 31.8% (6 days). In contrast, the 
simple immersion collagen-coated electrospun PCL increased 
only by 5.5% (2 days), 11.0% (4 days), and 21.0% (6 days) 
(Figure 5a). In addition, for the PCL involved nanoﬁ  bers, we 
also found that the HDFs could penetrate beneath the collagen-
r-PCL composite nanoﬁ  bers (Figure 5b). However, there is no 
such ﬁ  nding either in the pristine PCL or the simple immersion 
collagen-coated PCL nanoﬁ  brous scaffold. This study suggests 
that current core-shell composite nanoﬁ  bers tend to resemble 
the natural ECM architectural constituent of collagen, which 
makes cells have a propensity to interact well with them. Core-
sheath nanoﬁ  bers would also be a possible solution for the 
a b
c d
Figure 4 Coaxial electrospinning were employed to develop core-shell nanoﬁ  bers (a)(Zhang, Huang et al 2004), self-assembled FePt magnetic nanoparticles (ca. 4 nm) 
encapsulated nanoﬁ  bers (b) (Song, Zhang et al 2005), hollow nanoﬁ  bers (c) (Li and Xia 2004), and multichannel tubes (d) (Zhao, Cao et al 2007).International Journal of Nanomedicine 2007:2(4) 633
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components-incompatible-induced limited improvement in the 
mechanical properties as discussed in section 2.1.
Except for coaxial electrospun core-shell nanoﬁ  bers, 
other means such as previously used immersion coating (He, 
Ma et al 2005; Zhang, Venugopal et al 2005) and chemical 
conjunctions (Chua, Lim et al 2005; Ma, He et al 2005; Kim 
and Park 2006; Park, Kim et al 2006; Casper, Yang et al 
2007; Zhu, Leong et al 2007) have also been attempted to 
make bioactive molecules coated nanoﬁ  bers as summarized 
in Table 3. However, it should be noted that simple immer-
sion coating could make the coating happened only on the 
shallow layer of the whole nanoﬁ  brous structure rather than 
on each individual ﬁ  ber because of the hydrophobicity of 
aliphatic polyesters (eg, PLA and PCL) and nanoﬁ  brous 
structure contributed hydrophobic effect (Feng, Li et al 
2002; Neimark, Kornev et al 2003). For the chemical surface 
modiﬁ  cation method, to have desired biomolecules conju-
gated on the nanoﬁ  ber surface, the inert electrospun nanoﬁ  -
bers are usually subjected to pretreatment via technique like 
argon plasma or UV irradiation to generate reactive species 
such as carboxylic or hydroxyl. This severe pretreatment 
would likely affect the mechanical properties of the delicate 
nanoﬁ  bers. Furthermore, as the plasma effect only happens 
to a depth of several hundred angstroms, a deeper surface 
modiﬁ  cation of the nanoﬁ  brous scaffold structure may be 
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Figure 5 Core-shell structured collagen-r-PCL nanoﬁ  bers favored HDFs proliferation (a) and cellular inﬁ  ltration (b) (Zhang, Venugopal et al 2005).
Table 3 Core-shell structured nanoﬁ  ber scaffolds
Scaffold materials  Solvents  Diameters of   Cells cultured  Potential uses for  References
  used  electrospun     tissue  
   ﬁ  bers    engineering 
Collagen-r-PCL TFE  385 ± 82 nm  Fibroblasts  Skin  (Zhang, Venugopal et al 2005)
Collagen-P(LLA-CL) Aqueous  HCl,  470 ± 130 nm  HCAECs  Vascular graft  (He, Ma et al 2005)
 DCM/DMF 
Gelatin-[PMAA]-PET  TFA  200–600 nm  Endothelial cells  Blood vessel  (Ma, Kotaki et al 2005)
Galactose -[PAAc]-  Acetone  760 nm  Hepatocytes  Liver  (Chua, Lim et al 2005)
PCLEEP 
BMP-2-[SMCC]-Chitosan  HFIP  /  Osteoblastic MC3T3 cell  Bone  (Park, Kim et al 2006)
Gelatin-[EDAC]-PCL  Chloroform/  200–1000 nm  Endothelial cells  Blood vessel  (Ma, He et al 2005)
 DMF  (70:30) 
Fibronectin-PLLC  HFIP  100–500 nm  Porcine esophageal  esophagus  (Zhu, Leong et al 2007)
     epithelial  cells 
RGD-(PLGA-b-PEG-NH2) DMF/THF  (1:1) 449 ± 150 nm  NIH3T3 ﬁ  broblasts  /  (Kim and Park 2006)
/PLGA 
PlnDI-collagen (or gelatin)  HFIP  2–6 μm  MG63 osteoblastic cells  Bone  (Casper, Yang et al 2007)
Abbreviations: BMP-2, bone morphogenetic protein-2; DCM, dichloromethane; DMF, N,N-dimethyl formamide; EDAC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride; HCAEC, human coronary artery endothelial cell; HCl, Hydrochloric acid; PAAc, poly(acrylic acid); PCL, poly(ε-caprolactone); PCLEEP, poly(e-caprolactone-co-
ethyl ethylene phosphate); PET, poly(ethylene terephthalate); PlnDI, perlecan domain I; PLGA, poly(D,L-lactic-co-glycolic acid); PLLC, poly(L-lactide-co-caprolactone); PMAA, 
poly(methacrylic acid); SMCC, succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate; RGD, Arg-Gly-Asp; TFA, triﬂ  uoroacetic acid; THF, tetrahydrofuran. International Journal of Nanomedicine 2007:2(4) 634
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Delivery of bioactive molecules
If drugs or bioactive agents are encapsulated by a shell 
polymer, core-shell electrospun nanoﬁ  bers can be used 
for functional drug delivery. In this regard, coaxial 
electrospinning might be particularly suitable for mak-
ing biomimetic scaffolds with drug delivery capability. 
The advantage is that it does not require the drug to be 
electrospinnable or for it to have good physicochemi-
cal interaction with the carrier polymer. In contrast, for 
the cases of drugs loaded by blend electrospinning, poor 
interaction between the drug and polymer (Luu, Kim et al 
2003; Zeng, Xu et al 2003; Kim, Luu et al 2004; Zeng, Y 
ang et al 2005), and drug non-electrospinnability (Zhang, 
Wang et al 2006) both tremendously affect the drug distri-
bution in the polymer matrix and consequently the release 
behavior. The beneﬁ  ts of using core-shell nanoﬁ  bers for 
such a purpose are quite obvious. Firstly, it will be able to 
preserve those labile biological agents such as DNA and 
growth factors from being deactivated or denatured even 
when the applying environment is aggressive. In fact, such 
protection begins as early as during the fabrication stage 
because, unlike blend electrospinning, the aqueous solution 
containing bioactive agents and the shell polymer solution 
are separately prepared and pumped through different 
spinning channels. This would greatly reduce the possible 
inﬂ  uence of being exposed to organic solvents. Secondly, 
core-shell nanoﬁ  bers belong to reservoir type drug release 
device; therefore it will be possible to address the burst 
release problem noted in those electrospun ﬁ  bers where 
drugs were usually incorporated through electrospinning 
a blend of the drug and polymer carrier (Kenawy, Bowlin 
et al 2002; Zong, Kwangsok et al 2002; Luu, Kim et al 
2003; Kim, Luu et al 2004). Furthermore, by manipulating 
the core-shell nano-/micro-structure, desired and controlled 
releasing kinetics could be achieved.
Sustainable release of proteins or drugs with core-shell 
nanoﬁ  bers have recently been demonstrated by us and others 
(Jiang, Hu et al 2005; Huang, He et al 2006; Zhang, Wang 
et al 2006). Jiang et al (Jiang, Hu et al 2005) encapsulated 
BSA and lysozyme in PCL nanoﬁ  bers and found the released 
lysozyme maintained its structure and bioactivity. Huang 
et al coaxial electrospun Resyeratrol (RT, an antioxidant) 
and Gentamycin Sulfate (GS, an antibiotic) loaded nanoﬁ  -
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Figure 6 Schematic illustration showing the formation of larger pores by electrospinning of mingled nanoﬁ  bers and in situ leaching out of the water soluble nanoﬁ  bers (red 
lines) during cell cultivation (Zhang 2004).International Journal of Nanomedicine 2007:2(4) 635
Biomimetic and bioactive nanoﬁ  brous scaffolds
we demonstrated the burst-release suppressing ability of 
core-shell nanoﬁ  bers by entrapping a ﬂ  uorescein-conjugated 
BSA in the PCL shell. These results will provide a basis for 
further design and optimization of processing conditions to 
control the core-sheath nanostructure so as to achieve highly 
sustainable, controllable, and effective bioactive factor 
releases. In the context of tissue engineering applications, 
as delivery of growth factors is indispensable in the course 
of tissue regeneration, it is believed that coaxial electrospin-
ning and the produced core-shell nanoﬁ  bers will have great 
potential to locally regulate cellular process for a prolonged 
time through controlled release of these appropriate growth 
factors directly into the cell living microenvironment.
Nanoﬁ  bers mingled structure
Mingled nanoﬁ  bers refer to two (or more) different nano-
ﬁ  bers which are concurrently electrospun to attain random 
and homogenous hybridization of them at individual ﬁ  ber 
level. Besides envisioning achievable advantages in physical 
and mechanical properties, one of the most attractive points 
for the nanoﬁ  bers mingled structure is that it could offer a 
solution to cell penetration problem associated with the elec-
trospun nanoﬁ  brous scaffolds (Zhang 2004). The working 
principle as shown in Figure 6 is by simultaneously electros-
pinning two kinds of biodegradable and biocompatible poly-
mers (one of them being water soluble) to form nanoﬁ  bers 
randomly mingled structure. From here, larger pores can then 
be formed in situ through leaching out of the water soluble 
nanoﬁ  bers during cell culture. Formation of larger space can 
thus encourage cellular inﬁ  ltration. This concept was also 
previously proposed by Kidoaki et al (Kidoaki, Kwon et al 
2005) and implemented by co-electrospinning segmented 
polyurethane (SPU) with poly(ethylene oxide) (PEO) to 
form mixed ﬁ  ber mesh (Figure 7). But experimental in vitro 
cell culture work to provide evidence of cell inﬁ  ltration has 
not been attempted by anyone yet. Very recently, Duan 
et al (2007) simultaneously electrospun PLGA and blend of 
chitosan/PVA to generated mingled PLGA-chitosan/PVA 
composite nanoﬁ  brous scaffolds. They found such a man-
ner of introducing chitosan/PVA component had changed 
the hydrophilic/hydrophobic balance, and consequently 
inﬂ  uenced degradation and mechanical properties as well 
as cell attachment, proliferation and migration with the 
nanoﬁ  brous scaffolds.
Indeed, although electrospun nanoﬁ  bers can resemble the 
physical dimensions of the native ECM constituents, the small 
pores/interstices formed from nanoﬁ  ber lacing of each oth-
ers will be too small for cells to pass through (Eichhorn and 
Sampson 2005; Kidoaki, Kwon et al 2005; Badami, Kreke 
et al 2006; Pham, Sharma et al 2006; Stankus, Guan et al 
2006). Despite the fact that numerous research works have 
revealed favorable cell adhesion, proliferation and phenotype 
preservation and functions on the electrospun nanoﬁ  brous 
scaffolds, supporting cellular ingrowth to form cell-scaffold 
integrated 3-D complex is a critical issue that needs to be 
resolved. After all, formation of merely a monolayer of cells 
on the electrospun nanoﬁ  brous scaffolds has limited applica-
tion in tissue engineering. To overcome the cell inﬁ  ltration 
problem and achieve a highly cellularized tissue engineered 
construct in addition to the ﬁ  ber leaching methods of creating 
micropores or microvoids in situ (Kidoaki, Kwon et al 2005; 
Zhang, Ouyang et al 2005; Zhang, Feng et al 2006), different 
approaches and strategies have been adopted by researchers. 
For instance, simultaneous electrospinning nanoﬁ  bers and 
living cells to achieve a uniform distribution of cells through 
the scaffold thickness had been proposed (Stankus, Guan 
et al 2006). Alternatively, using coaxial electrospinning to 
directly produce cells-encapsulated nanoﬁ  ber scaffolds is 
also possible to generate three dimensional distribution of 
cells within the electrospun scaffolds (Townsend-Nicholson 
and Jayasinghe 2006). Pham et al (Pham, Sharma et al 2006) 
electrospun PCL scaffolds consisting of alternating layers 
    (a) (b)       (c)
Figure 7 Confocal laser scanning micrographs of electrospun mingled ﬁ  brous structure of SPU/PEO. (a) Bottom region of the mixed ﬁ  ber mesh. SPU and PEO were stained 
with rhodamine and FITC, respectively. (b) Middle region of the mesh observed at the 4 μm-upper region than (a). (c) Top region of the mesh observed at the 4 μm-upper 
region than (b) (Kidoaki, Kwon et al 2005). Scale bar 10 μmInternational Journal of Nanomedicine 2007:2(4) 636
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of relatively larger microﬁ  bers (2~10 μm) and nanoﬁ  bers to 
investigate cell inﬁ  ltration.
So far, there has been work reporting cellular ingrowth 
to some extent (Matthews, Wnek et al 2002; Bhattarai, 
Bhattarai et al 2004; Stankus, Guan et al 2004; Telemeco, 
Ayres et al 2005; Zhang, Ouyang et al 2005; Li, Mondrinos 
et al 2006). Cellular ingrowth phenomenon was explained as 
a result of bioactivity effect due to incorporation of bioactive 
components. In addition to this, appropriate nanomechani-
cal properties of the scaffold nanoﬁ  bers also allow cells to 
enter into the matrix through amoeboid movement to push 
the surrounding ﬁ  bers aside to make necessary spaces. In 
spite of these experimental results, whether the electrospun 
nanoﬁ  brous scaffolds support cell inﬁ  ltration is still open to 
debate. Systematic investigation from materials selection, 
manipulated geometry and physical properties of nanoﬁ  brous 
scaffolds, to the cell types, culture methods and conditions 
need to be performed. We believe while endowing nanoﬁ  bers 
with appropriate wettability and biochemical signals would 
be workable for facilitating and encouraging cell migration 
into the scaffold interior as reported in our work and others 
(Stankus, Guan et al 2004; Telemeco, Ayres et al 2005; Zhang, 
Ouyang et al 2005; Badami, Kreke et al 2006), physical char-
acteristics such as pore size, pore structure, pore distribution 
and the overall porosity of the nanoﬁ  brous scaffolds would 
equally play important role. Both will have direct inﬂ  uence on 
supply of the oxygen and nutrients to the cells and removal of 
waste products – which are the determinant factors for cellular 
inﬁ  ltration (Sachlos and Czernuszka 2003).
Concluding remarks
It has been widely acknowledged in the tissue engineering 
research community that nanoﬁ  bers produced from electrospin-
ning technique are able to emulate the architecture of the native 
extracellular matrix, which is a complex ﬁ  brous network of 
proteins and glycosaminoglycans with hierarchical dimensions 
down to nanometer scale. Here, we discussed the potential of 
using electrospun composite nanoﬁ  bers, in the form of compo-
nents blended, core-shell structured, and nanoﬁ  brous mingled 
structures for developing biomimetic and bioactive cellular 
scaffolds, as well as the limitations and issues to be resolved.
In comparison to those commonly used biodegradable 
and biocompatible synthetic polymers, the strategy of intro-
ducing natural bioactive components into biologically inert 
but mechanically meritorious synthetics and converting such 
combinations into nanoﬁ  ber form offers a facile approach 
to bioactivate and functionalize nanofibrous scaffolds. 
Because of the versatility of electrospinning, with currently 
established knowledge and understanding about the struc-
ture, constituents, and functions of ECM, it is conceivable 
that more elaborate biological recognition and signaling 
functions of the extracellular milieu can be integrated into 
the nanoﬁ  brous scaffolds for even precise recapitulation and 
spatiotemporal control in vitro and in vivo of the cell living 
environment. On the other hand, as interplays between cells 
and artiﬁ  cial scaffolds are crucial for modulating cellular 
functions in vitro and in vivo, the bioactive composite nano-
ﬁ  brous scaffolds might be an ideal biomimic platform for 
systematic research to enhance our understanding on cell-
matrix interactions from which future design and fabrication 
of biomimetic nanoﬁ  brous scaffolds can be achieved and 
implemented in an accurate and rational manner.
It is believed endowing electrospun nanoﬁ  bers bioactivity 
and biological functions will represent the mainstream trend in 
future nanoﬁ  brous scaffold related research activities. In this 
sense, with continual advances in electrospinning technology 
and biological evaluation of such scaffolds, biomimetic and 
bioactive composite nanoﬁ  bers will be the right candidate 
materials in fulﬁ  lling the successful application of nanoﬁ  bers 
in tissue engineering and regenerative medicine.
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